Pure Biologics S.A. (FRA:PQB)
0.9245
-0.0115 (-1.23%)
Last updated: Jan 8, 2026, 8:03 AM CET
Pure Biologics Market Cap
Pure Biologics has a market cap or net worth of €8.25 million as of January 9, 2026. Its market cap has decreased by -45.20% in one year.
Market Cap
8.25M
Enterprise Value
11.78M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.92
Market Cap Chart
Since December 11, 2018, Pure Biologics's market cap has increased from 6.24M to 8.25M, an increase of 32.22%. That is a compound annual growth rate of 4.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 8.25M | 19.79% |
| Dec 30, 2025 | 6.89M | -54.35% |
| Dec 30, 2024 | 15.09M | 55.88% |
| Dec 29, 2023 | 9.68M | -12.63% |
| Dec 30, 2022 | 11.08M | -71.01% |
| Dec 30, 2021 | 38.22M | -5.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |